Comparing Kaya (KAYS) & Its Rivals

Kaya (OTCMKTS:KAYSGet Free Report) is one of 1,000 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it contrast to its competitors? We will compare Kaya to similar companies based on the strength of its institutional ownership, profitability, risk, valuation, earnings, analyst recommendations and dividends.

Earnings & Valuation

This table compares Kaya and its competitors gross revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Kaya $200,000.00 $1.61 million -1.75
Kaya Competitors $1.68 billion $147.25 million -1.33

Kaya’s competitors have higher revenue and earnings than Kaya. Kaya is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Insider & Institutional Ownership

44.5% of shares of all “Pharmaceutical preparations” companies are owned by institutional investors. 23.5% of Kaya shares are owned by company insiders. Comparatively, 14.2% of shares of all “Pharmaceutical preparations” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Kaya and its competitors, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kaya 0 0 0 0 N/A
Kaya Competitors 6384 18714 44577 917 2.57

As a group, “Pharmaceutical preparations” companies have a potential upside of 84.65%. Given Kaya’s competitors higher possible upside, analysts clearly believe Kaya has less favorable growth aspects than its competitors.

Risk and Volatility

Kaya has a beta of 0.54, meaning that its stock price is 46% less volatile than the S&P 500. Comparatively, Kaya’s competitors have a beta of 1.12, meaning that their average stock price is 12% more volatile than the S&P 500.

Profitability

This table compares Kaya and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Kaya 821.43% -9.57% 638.26%
Kaya Competitors -2,458.79% -294.93% -30.61%

Summary

Kaya competitors beat Kaya on 6 of the 10 factors compared.

About Kaya

(Get Free Report)

Kaya Holdings, Inc., a vertically integrated legal cannabis enterprise, produces, distributes, and/or sells a range of cannabis products primarily in the United States. The company offers flower, oils, vape cartridges and cannabis infused confections, baked goods, and beverages. It also operates retail outlets under the Kaya Shack brand name, as well as offers strain specific cannabis cigarettes under the Kaya Buddies name, and strains of cannabis under the Kaya Farms name. In addition, the company provides standing display cases with cannabis intended glassware under the Really Happy Glass brand; and t-shirt designs under the Kaya Gear brand name. The company was formerly known as Alternative Fuels America, Inc. and changed its name to Kaya Holdings, Inc. in April 2015. Kaya Holdings, Inc. was incorporated in 1993 and is headquartered in Fort Lauderdale, Florida.

Receive News & Ratings for Kaya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kaya and related companies with MarketBeat.com's FREE daily email newsletter.